Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fine Chemical Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel carbonylation method using sulfonyl chlorides avoids toxic thiols. High purity thioesters for pharma intermediates with simplified supply chain.
Patent CN108689892B discloses a novel CuI-catalyzed route for 3-sulfonylated indanones, offering mild conditions and high yields for cost-effective pharmaceutical intermediate manufacturing.
Patent CN115353511A details a safe, multi-component synthesis of trifluoromethyl-biheterocycles using palladium catalysis, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for pharmaceutical intermediates without heavy metals.
Patent CN117720537B reveals novel catalyst enabling high-purity asymmetric synthesis with reduced costs and scalable supply chain reliability for global buyers.
Patent CN115043736A reveals a metal-free route for C-N coupling, offering cost-effective production of pharmaceutical intermediates with high purity.
Patent CN102464613A reveals a mild, high-yield quinoline synthesis using Lewis acids and oxidants. Ideal for reliable pharmaceutical intermediate suppliers seeking cost reduction.
Patent CN112047839B reveals a visible-light driven method for high-purity 1-iodo-3-perfluoroalkyl alkenes. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN113105402B reveals a metal-free iodine-promoted synthesis for trifluoromethyl triazoles, offering significant cost reduction in API manufacturing and simplified purification.
Novel Pd/Cu catalyzed route offers high yields and simplified purification for complex pharmaceutical intermediates, ensuring supply chain stability.
Patent CN111423381B reveals a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering reliable supply and cost-effective API intermediate manufacturing.
Patent CN115353511A details a novel multi-component Pd-catalyzed carbonylation for synthesizing indolinone-imidazole hybrids, offering cost-effective routes for API intermediates.
Patent CN111423381B details a mild Pd-catalyzed route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply with enhanced cost efficiency.
Patent CN114773242A details a novel nickel-catalyzed route for alpha,beta-unsaturated thioesters, offering cost-effective alternatives to precious metal methods for pharmaceutical intermediates.
Patent CN113105402B reveals a metal-free iodine-promoted route for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN102180794B details a mild, aqueous synthesis of nitrobenzenes from arylboronic acids, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113045489A details a novel Pd-catalyzed route to quinolinone derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115353511A discloses a safe, multi-component palladium-catalyzed method for synthesizing carbonyl-bridged biheterocycles using in-situ carbon monoxide generation.
Patent CN114160206B details a novel chiral copper catalyst achieving >91% ee and >81% yield for 3-alkenyl-3-substituted oxindoles, offering scalable API intermediate solutions.
Patent CN113307778A reveals a mild Mo/Cu-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.